Somatostatin receptor saturation after administration of high peptide amounts of [(177)Lu]Lu-HA-DOTATATE: when enough is enough

BACKGROUND: Receptor saturation during peptide receptor radionuclide therapy (PRRT) could result in altered [(177)Lu]Lu-HA-DOTATATE uptake in tumors and organs. Therefore, receptor expression status and effects of different (unlabeled) administered peptide amounts during PRRT need to be evaluated. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Siebinga, Hinke, Veerman, Chayenne H. A. M., de Wit-van der Veen, Linda, Stokkel, Marcel P. M., Hendrikx, Jeroen J. M. A., Aalbersberg, Else A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751249/
https://www.ncbi.nlm.nih.gov/pubmed/36515683
http://dx.doi.org/10.1186/s13550-022-00946-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751249/
https://www.ncbi.nlm.nih.gov/pubmed/36515683
http://dx.doi.org/10.1186/s13550-022-00946-3

Ejemplares similares